KEYWORDS
Technology and Procedures, Assays, Omics Technologies, Bioinformatics, Cell Expansion, Profiling, Treatment Considerations, Biological Therapies, Transplantation, Chimeric Antigen Receptor, (CAR)-T Cell Therapies, Gene Therapy, Immunotherapy, Biological Processes, Pathogenesis, Immune Mechanism, Metabolism, Microbiome, Diseases, Immunology, GVHD, Lymphoid Malignancies, Lymphoid Leukemias, Plasma Cell Disorders, Myeloid Malignancies, Acute Myeloid Malignancies, ALL, Research, AML, Translational Research, Study Population, Human, Animal Model